Kilitch Drugs (India) Limited (BOM:524500)
India · Delayed Price · Currency is INR 185.60
+1.05 (0.57%)
At close: Jun 16, 2026
Kilitch Drugs (India) Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 301.66 | 267.01 | 146.01 | 104.48 | 73.67 |
Depreciation & Amortization | 36.23 | 21.59 | 23.38 | 26.96 | 16.13 |
Other Amortization | - | 1.08 | 1.69 | 0.13 | 0.1 |
Asset Writedown & Restructuring Costs | - | 8.43 | 8.43 | 8.43 | 8.43 |
Loss (Gain) From Sale of Investments | -36.23 | -65.22 | -13.89 | -9.88 | -13.59 |
Loss (Gain) on Equity Investments | -0.06 | 0 | 0.02 | 0.02 | 0.02 |
Provision & Write-off of Bad Debts | 34.47 | 11.6 | 31.39 | 31.39 | 10.86 |
Other Operating Activities | 24.54 | 27.19 | 30.74 | 13.18 | 14.11 |
Change in Accounts Receivable | -375.34 | -220.75 | -119.17 | -154.88 | -202.97 |
Change in Inventory | 37.89 | -113.22 | -19.43 | 29.56 | -14.14 |
Change in Accounts Payable | 254.89 | 285.69 | -122.86 | -19.95 | 227.15 |
Change in Other Net Operating Assets | -38.5 | -47.98 | 18.34 | -3.57 | -61.94 |
Operating Cash Flow | 239.58 | 175.42 | -15.35 | 25.86 | 57.83 |
Operating Cash Flow Growth | 36.57% | - | - | -55.29% | -87.33% |
Capital Expenditures | -995.07 | -468.73 | -64.5 | -38.12 | -82.02 |
Investment in Securities | -5.34 | 52.66 | -15.72 | 94.34 | -72.98 |
Other Investing Activities | -3.95 | 16.61 | -1.34 | 22.93 | 2.49 |
Investing Cash Flow | -1,004 | -399.47 | -81.56 | 79.15 | -152.5 |
Short-Term Debt Issued | - | 177.78 | 94.53 | 17.62 | 56.28 |
Long-Term Debt Issued | 392.85 | - | - | - | - |
Total Debt Issued | 392.85 | 177.78 | 94.53 | 17.62 | 56.28 |
Net Debt Issued (Repaid) | 392.85 | 177.78 | 94.53 | 17.62 | 56.28 |
Issuance of Common Stock | 487.28 | - | 38.58 | - | 0.88 |
Other Financing Activities | -55.61 | -45.34 | -45.04 | -24.78 | 13.12 |
Financing Cash Flow | 824.53 | 132.43 | 88.07 | -7.16 | 70.28 |
Miscellaneous Cash Flow Adjustments | - | - | 0 | - | - |
Net Cash Flow | 59.73 | -91.61 | -8.84 | 97.85 | -24.39 |
Free Cash Flow | -755.5 | -293.31 | -79.85 | -12.26 | -24.19 |
Free Cash Flow Margin | -32.08% | -14.79% | -5.17% | -0.88% | -2.12% |
Free Cash Flow Per Share | -22.32 | -9.12 | -2.51 | -0.39 | -0.78 |
Cash Interest Paid | 55.61 | 50.41 | 59.29 | 49.19 | 11.98 |
Cash Income Tax Paid | 105.41 | 84.7 | 70.36 | 43.31 | 25.36 |
Levered Free Cash Flow | -888.17 | -370.5 | -175.19 | -74.79 | -364.59 |
Unlevered Free Cash Flow | -853.42 | -339 | -138.13 | -44.04 | -357.1 |
Change in Working Capital | -121.05 | -96.26 | -243.12 | -148.84 | -51.9 |